Xiaopei Cui
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Metabolism, Diabetes, and Cancer 3
-
- Pulmonary Hypertension Research and Treatments 5
- Co-authors
- Zhen Chen (4 shared papers)Shu Chien (2 shared papers)I‐Chen Peng (2 shared papers)Yi‐Shuan Li (1 shared paper)Haiqing Gao (12 shared papers)Deyue Yu (2 shared papers)Hui Yang (2 shared papers)Hongyang Du (2 shared papers)
- Journals
- International Immunopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Immunology (2 papers)Annals of Translational Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaopei Cui
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Geriatrics and Gerontology 107
- Biochemistry 91
- Toxicology 50
- Cancer Research 169
- Molecular Biology 590
Countries citing papers authored by Xiaopei Cui
This map shows the geographic impact of Xiaopei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopei Cui more than expected).
Fields of papers citing papers by Xiaopei Cui
This network shows the impact of papers produced by Xiaopei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopei Cui. The network helps show where Xiaopei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 244 | |
| 2 | 2015 | 211 | |
| 3 | 2013 | 157 | |
| 4 | 2008 | 76 | |
| 5 | 2013 | 69 | |
| 6 | 2012 | 61 | |
| 7 | 2012 | 41 | |
| 8 | 2021 | 40 | |
| 9 | 2010 | 35 | |
| 10 | 2013 | 31 | |
| 11 | 2012 | 26 | |
| 12 | 2016 | 25 | |
| 13 | 2020 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 15 | |
| 17 | 2021 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2018 | 14 | |
| 20 | 2022 | 13 |
About Xiaopei Cui
Xiaopei Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (5 papers), Metabolism, Diabetes, and Cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Advanced Glycation End Products research (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Hormonal and reproductive studies (2 papers), Forensic Toxicology and Drug Analysis (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Geriatrics and Gerontology (107 citations), Biochemistry (91 citations), Toxicology (50 citations), Cancer Research (169 citations) and Molecular Biology (590 citations). Xiaopei Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhen Chen, Shu Chien, I‐Chen Peng, Yi‐Shuan Li, Haiqing Gao, Deyue Yu, Hui Yang, Hongyang Du, Xuanrui Zeng and Hao Cheng. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Frontiers in Immunology, Annals of Translational Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.